Nexgel (NXGLW) Research & Development (2021 - 2025)
Nexgel's (NXGLW) quarterly Research & Development came in at -$6000.0 in Q4 2025, down 185.71% on a QoQ basis from $7000.0 in Q3 2025.
Nexgel (NXGLW) Research & Development (2021 - 2025) Analysis & Trends
Nexgel (NXGLW) has 5 years of Research & Development data on file, last reported at -$6000.0 in Q4 2025.
- Quarterly Research & Development changed N/A year-over-year to -$6000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2000.0 (down 97.44% YoY) and the FY2025 annual result came in at $2000.0, down 97.44% from the prior year.
- Research & Development retreated to -$6000.0 in Q4 2025, from $7000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $193000.0 in Q3 2022 to a low of -$6000.0 in Q4 2025.
- A 5-year average of $36312.5 and a median of $13500.0 in 2021 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 1010.0% — and 2023, when it sank 96.89%.
- Tracing NXGLW's Research & Development over 5 years: stood at $14000.0 in 2021, then surged by 178.57% to $39000.0 in 2022, then slumped by 66.67% to $13000.0 in 2023, then jumped by 484.62% to $76000.0 in 2024, then sank by 107.89% to -$6000.0 in 2025.
- The last three Research & Development figures came in at -$6000.0 (Q4 2025), $7000.0 (Q3 2025), and $1000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Jun 30, 2024 | 76,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 193,000.00 |
| Jun 30, 2022 | 111,000.00 |
| Mar 31, 2022 | 24,000.00 |
| Dec 31, 2021 | 14,000.00 |
| Jun 30, 2021 | 10,000.00 |
| Mar 31, 2021 | 7,000.00 |